Book your Virtual Summit pass at £145

Innovative solutions to the greatest challenges in pharmaceutical development

15th – 17th March 2021

The 2021 Virtual Summit covers both small molecules and biologicsnew technologies, concepts and case studies in areas such as:

  • Formulation design for poorly soluble compounds
  • The potential of nanotechnology for better deliverability
  • The latest controlled released technologies
  • Improving patient compliance by harnessing data and the latest smart device technology
  • Optimising formulations for continuous manufacturing
  • Overcoming the blood brain barrier and challenges in oral delivery of biologics
  • Reformulation and biosimilars

2021 Speakers

Carolin Auch


Principal Scientist | Lab Head Drug Delivery & Innovation

Dr. Fatima Bennai-Sanfourche


Director Medical device Safety, Medical Device Safety Officer

Erwan Bourles


Senior Manager, Head of Drying and Related Modelling Technologies Drug Product development Unit

Olivier Brass


Senior scientist, lead of research unit, research department

Matthew Clemente

Novo Nordisk

Vice President, Device Development, Device R&D

Gabriele Sadowski

TU Dortmund

Professor for Thermodynamics

Robert Hennig


Associate Director Drug Delivery & Innovation, Healthcare R&D

Karsten Fluegel


Postdoctoral Researcher | Drug Delivery & Innovation

Naila El Kechai


Formulation and Drug Product Team Leader

Claus-Michael Lehr

Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)

Head, Dept. of Drug Delivery (DDEL)

Kenneth J. Mandell


Founder and CEO

Dr Ana L Gomes dos Santos


Principal Scientist

Stefan Schneid


Laboratory Head Formulation Development Parenterals

Ijeoma F. Uchegbu

University College London

Chair in Pharmaceutical Nanoscience

Kerstin Walke

Boehringer Ingelheim

Head of Pharmaceutical Development Biologicals

Latest News

Upperton Invest £500K in their Tablet Formulation and Manufacturing Capabilities

Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO) have invested £500K in significantly expanding their tablet manufacturing capabilities with the addition of tablet processing equipment for wet granulation, roller compaction, tablet compression, hardness testing, dedusting, weight sorting and tablet coating throughout 2019 and 2020. This investment of £500K will enhance the company’s development and manufacturing capabilities whilst strengthening their ability to support clients’ research, development and clinical manufacturing needs.

Partner profile: Crux Product Design

With the experience of delivering product innovations in the medical, consumer and performance goods sectors, we have the expertise to adapt and apply our methods to each client’s specific project needs.

Updates from Sensile Medical

Our partner Sensile Medical have an update on two of its major projects: The recent market launch of their first micropump, an infusion pump for Parkinson's disease patients; and their latest project with SQ Innovation for a 3mL furosemide patch pump. they have sent us 3 documents to present to our followers and audience